• SENSEX 71,924.68
    -547.65 (--0.76%)
  • BANKNIFTY 54,918.00
    -338.65 (--0.61%)
  • Lenskart Solut.
    643.80 355.70(%)
  • IndusInd Bank
    846.35 725.90(%)
  • Shadowfax Technologies
    275.10 98.60(%)
  • Life Insurance
    388.70 361.00(%)
  • NSE
    1,725.50 1,712.00(%)
  • Religare Enterp.
    227.50 284.85(%)
  • Axis Bank
    1,244.60 1,150.50(%)
  • LIC Housing Fin.
    566.90 598.00(%)
  • Infosys
    1,010.40 980.30(%)
  • Swiggy
    230.35 230.35(%)
  • Moneyview
    60.72 48.33(%)
  • Delhivery
    424.15 524.25(%)
  • DLF
    653.95 786.40(%)
  • Gallantt Ispat L
    604.80 946.70(%)
  • Poonawalla Fin
    483.95 544.95(%)
  • Kanohar Elect.
    1,100.35 672.05(%)
  • Jubilant Pharmo
    965.50 1,183.90(%)
  • Jindal Steel
    1,039.95 1,306.00(%)
  • Reliance Industries
    1,153.10 1,153.10(%)
  • Cupid
    356.05 45.40(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Alpa Laboratories Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 27710.0
  • ISIN : INE385I01010
55.80 -1 (-2.09%)
  • As on 12 Oct 2026 (EOD)

  • Today’s Low

    55.15

  • Today’s High

    58.13

  • Open

    58.09

  • Perv Close

    56.99

  • 52W Low

    46.10

  • 52W High

    93.85

Key Indicators

  • P/E(TTM)

    27.69

  • Mar.Cap (₹Cr.)

    117.41

  • Div & Yield %

    0.00

  • Book Value(₹)

    93.43

  • Debt-Equity Ratio

    -2.09

  • AGM Date

    12-Oct-2026

  • EPS

    2.08

  • P/E Ratio

    27.69

Financials Ratios

  • Debt-Equity Ratio

    0.03

  • Mar.Cap (₹Cr.)

    117.41

  • RONW (%)

    11.71

  • ROCE (%)

    14.32

Score Board

  • Equity (₹ in Cr.)

    21.04

  • BV (₹)

    93.40

  • Sales( ₹ in Cr.)

    105.81

  • NP (in Cr.)

    14.95

  • NP Var(%)

    -24.0

  • Div%

    0.0

  • CPS (₹)

    8.10

  • EPS (₹)

    7.10

  • Traded Value (₹ in Lakhs)

    121.19

  • 52 Week High

    93.85

  • 52 Week Low

    46.10

  • Price BSE

    58.0

  • Price NSE

    56.00

  • Market Capital( in Cr.)

    121.19

  • P/C Ratio

    7.20

  • P/E Ratio

    8.20

  • Price Vs.BV

    7.10

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 105.81 112.45 108.74 92.96 112.27 97.55
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 105.81 112.45 108.74 92.96 112.27 97.55
Other Income 15.72 23.31 14.87 9.41 10.79 4.41
Stock Adjustments -2.94 1.45 0.64 -1.27 -0.53 1.15
Total Income 118.59 137.21 124.25 101.10 122.53 103.11
EXPENDITURE :            
Raw Materials 63.42 71.65 68.68 53.67 69.24 60.62
Power and Fuel Cost 3.09 2.84 3.02 3.04 2.64 2.43
Employee Cost 15.80 14.37 13.26 12.17 11.93 11.75
Other Manufacturing Expenses 4.85 3.43 3.62 3.69 3.69 2.86
Selling and Administration Expenses 8.99 10.90 8.64 7.42 8.29 7.56
Miscellaneous Expenses 3.42 5.71 4.02 3.62 5.25 5.79
Employee Benefit Expenses 15.80 14.37 13.26 12.17 11.93 11.75
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 99.57 108.90 101.24 83.60 101.04 91.00
Operating Profit 19.02 28.31 23.02 17.48 21.48 12.12
Interest 0.29 0.27 0.39 0.22 0.24 0.10
Gross Profit 18.73 28.04 22.63 17.26 21.24 12.02
Depreciation 2.09 2.20 1.95 1.33 1.66 1.23
Profit Before Tax 16.64 25.84 20.68 15.93 19.58 10.79
Current Tax 2.84 4.06 3.00 3.60 3.10 2.39
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -1.16 2.10 0.90 -0.29 2.35 1.14
Reported Net Profit 14.95 19.68 16.78 12.62 14.13 7.26
Extraordinary Items 0.00 -0.04 -0.43 -0.01 6.38 2.10
Adjusted Net Profit 14.95 19.72 17.21 12.63 7.75 5.16
Adjustment below Net Profit -0.88 0.15 0.08 0.85 0.00 0.03
P & L Balance brought forward 106.51 85.97 69.11 55.64 41.51 34.23
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 120.58 105.80 85.97 69.11 55.64 41.52
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 7.11 9.35 7.97 6.00 6.71 3.45
Earnings Per Share(Adj)-Unit Curr 7.11 9.35 7.97 6.00 6.71 3.45
Book Value 93.43 86.41 76.98 68.97 62.56 55.85
Book Value(Adj)-Unit Curr 93.43 86.41 76.98 68.97 62.56 55.85

Shareholding Pattern

  • Promoter Group

    57.19%

  • Public Share Holding

    42.81%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 12,033,070 57.19 12,033,070 9
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 12,033,070 57.19 12,033,070 9
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 74,332 0.35 74,332 1
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 14,286 0.07 14,286 1
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 88,618 0.42 88,618 2
2] Non Institution
Bodies Corporate 179,576 0.85 179,576 40
Clearing Members 9,252 0.04 9,252 8
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 754,127 3.58 754,127 388
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 262,572 1.25 262,572 313
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,323,151 6.29 1,323,151 29
Individuals holding nominal share capital up to Rs. 1 lakh 6,390,234 30.37 6,385,034 16,854
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 8,918,912 42.39 8,913,712 17,632
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 21,040,600 100.00 21,035,400 17,643

Company Background

Alpa Laboratories LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Alpa Laboratories Ltd
  • BSE Code : 27710.0
  • ISIN : INE385I01010

  • Incorporation Year

    1988

  • Registered Office

    33/2 Pigdamber
    A B Road Rau, Indore,
    Madhya Pradesh-453446

  • Telephone

    91-731-4294567

  • FAX

    91-731-4294444

  • Chairman

    Mahendra Singh Chawla

  • Managing Director

    Purushottam R Patel

  • Company Secretary

  • Auditor

    C H Padliya & Co

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    Bigshare Services Pvt Ltd
    Office No S6-2,
    Pinnacle Busine.Park,Mahakali Caves Road
    Mumbai - Mumbai - 400093

Alpa Laboratories Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Alpa Laboratorie 57.60 121.53 105.81 27.69 8.91
Abbott India 25,800.35 7,217.19 6,929.05 33.95 43.78
Astrazeneca Phar 5,920.60 2,304.07 2,275.58 87.26 27.86
Glaxosmi. Pharma 2,531.40 3,932.76 3,790.20 40.44 58.17
Novartis India 2,013.35 393.10 354.33 50.84 15.94
Cipla 1,313.70 20,102.60 18,979.95 34.53 13.88
Bliss GVS Pharma 672.75 773.53 729.81 62.52 12.51
Fermenta Biotec. 519.40 474.15 450.25 24.25 18.77
Amrutanjan Healt 502.70 520.13 502.55 26.93 24.16
Guj. Themis Bio. 371.95 168.25 165.82 99.45 18.05
Ambalal Sarabhai 39.02 19.52 3.94 72.26 6.77